OssDsign Catalyst becomes universally available to all Military Treatment Facilities in the U.S. via ECAT
OssDsign AB (publ.) today announces that the company’s nanosynthetic bone graft, OssDsign Catalyst has been included in the Department of Defense’s Military Health System’s electronic catalogue (ECAT), which means that the product is now universally available and can be ordered directly from any of the more than 50 Military Treatment Facilities in the U.S.The uptake of OssDsign Catalyst in ECAT has been mediated through the previously communicated collaboration with Red One Medical, a private-sector scout of medical innovation for the Department of Veterans Affairs (VA) and the Department